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Patterns of Tuberculosis in the Central Nervous System
Soobia Raza1, Aliyah Sadaf1, Faisal Fecto1, Rushna Pervez Ali1, Ehsan Bari2, S. Ather Enam2
The Aga Khan University Medical College1, Section of Neurosurgery2, Aga Khan University Hospital, Karachi.
Introduction
Tuberculous involvement of central nervous system
(CNS), although not very frequent, results in severe morbidity.
Tuberculosis (TB) is endemic in developing countries but even
in developed countries, after an initial decline up until 1980’s,
incidence of TB is on the rise. The AIDS epidemic, emergence
of multi-drug resistant strains and immigration of people from
endemic areas are some of the factors significantly contributing
to this increase. Consequently, the burden of central nervous
system tuberculosis has increased significantly worldwide.
Infection of CNS by tuberculosis (TB) can develop
in several patterns. The old adage “Syphilis - the Great
Masquerader”, probably applies to tuberculosis as well when
it involves the central nervous system. This poses a constant
challenge to the clinicians in making a definitive diagnosis.
The various extra-pulmonary manifestations of tuberculosis
and the multitude of organs involved complicate the task further.
Central nervous system (CNS) tuberculosis forms a significant
proportion of extra-pulmonary tuberculosis1. In most cases,
infection is thought to spread hematogenously. Due to a lack
of reliable diagnostic tests and due to morbidity inherent in
surgical procedures for diagnosis, the decision to treat central
nervous system tuberculosis is done empirically in most endemic
areas. Thus its purulent to be cognizant of the patterns of CNS
infection by TB.

cisterns (basal arachnoiditis) resulting in communicating
hydrocephalus (Figure 1). An incidence of hydrocephalus as
high as 80% in tuberculous meningitis has been reported.
Accumulation of exudates in the basal regions may compress
optic chiasm, nerves and internal carotid arteries. Optochiastmatic arachnoiditis can lead to blindness in 5-10% of
cases with TBM. Patients with tuberculous meningitis are
clinically staged according to their presenting symptoms
and their stage at diagnosis correlates directly with individual
prognosis (Table 1).
Figure 1. MR image in a case of tuberculous meningitis.
Coronal cut showing enhancement of the meninges in the left Sylvian
fissure (a) and basal meninges (a,b). Resultant hydrocephalus is also
evident in the MR images particularly in (b)

(a)

There are four major patterns of CNS TB:
1234-

tuberculous meningitis (TBM)
tuberculomas in brain and spinal cord (TBT)
tubercular brain abscess (TBA)
tuberculous encephalopathy (TBE)

Tuberculous Meningitis
The most common form that tuberculosis takes in the
central nervous system is TBM. This is characterized by
accumulation in the meninges of gelatinous exudates commonly
affecting the cranial nerves. This exudate is composed of
mononuclear cells, epithelioid cells and Langhans’ giant cells.
It usually arises from subependymal regions from small caseous
foci known as “Rich” foci (Greenfield). Copious exudates of
TBM may cause obstruction in CSF flow at the level of basal

(b)
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Table 1
TUBERCULOUS MENINGITIS
Constitutional symptoms
Headache
Meningism
Carnial nerve palsies
Altered mental status, Focal
neurological deficits, nvulsions

80%
86%
25-30%
15-40%

INTRACRANIAL TUBERCULOMA

Two other conditions that need to be considered with
TBM are tuberculous vasculitis and tuberculous encephalitis4.
The exudative inflammatory change in the meninges may
extend along the perforating vessels and incite reactive
proliferation of microvessels. This extension can give rise to
encephalitis which may or may not be focal. Vasculitis may
cause thrombosis in the perforating and other small vessels and
occasionally in larger vessels such as middle cerebral artery
leading to ischemic changes and multiple infarcts, one of the
main perilous outcomes of TBM.

S/s of space occupying lesion
i.e. headache, seizures
Focal neurological deficits

60-100%

Tuberculomas

33-68%

S/s of raised intracranial pressure
Fever, signs of meningeal irritation
and cranial nerve palsies less
common

56-93%

A tuberculoma is an infrequent manifestation of central
nervous system tuberculosis. It may occur singly but is more
often multiple. In approximately 16% of patients, it may coexist with culture positive tuberculous meningitis5. At Aga
Khan University Hospital (AKUH), Karachi, Pakistan 246
patients were admitted during the period of 2000-2004 with
the suspicion of tuberculous meningitis. 89 (36.1%) of these
had tuberculomas, either with or without culture positive
tuberculous meningitis (unpublished observations).
The most common site for TBT is posterior cranial fossa
(Figure3).

TUBERCULAR BRAIN ABSCESS
Constitutional symptoms
Headache
Focal neurological deficits
Seizures
Altered consciousness

46%
47%
71%
35%
24%

In many developing countries tuberculous meningitis
is especially common in patients younger than 5 years. Infants
usually present with non-specific symptoms, which include
irritability, restlessness poor feeding, and physical signs of
hydrocephalus. In immunocompromised patients, tuberculous
meningitis manifests clinically in a similar manner. That TBM
complicates a significant number of TB in developing countries
and that TBM incidence is increasing progressively compared
to other extra-pulmonary TB even in developed countries is
shown in Figure 2.

Figure 3

(3a)

Figure 2a
2500

No of new cases of
tuberculous
meningitis/100,00
population

2000
1500
1000

No of new cases of
tuberculosis/100,00
0 population

500
0
Africa

Asia

US

Europe

(3b)

Figure 2b
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The reason for this is not well understood but might
be the predilection of TBM to occur in basal regions which
eventually gives rise to TBT. Posterior fossa location of TBT
is particularly more common in patients less than 20 years.
Compression of the CSF pathway either in the 4th ventricle or
at the cerebral aqueduct by tuberculomas gives rise to
hydrocephalus. Microscopically, it is composed of a caseous
center surrounded by a granulomatous reaction including giant
cells, lymphocytes and fibrosis. Unusual presentations of TBT
may consist of multiple small perivascular “incipient type”
granulomas which develop as gradual conglomeration on cortical
surface, miliary neuro-tuberculosis, cystic tuberculomas, and
tuberculomas in subdural or trans-dural locations6. Tuberculomas
were one of the most common space occupying lesions in the
beginning of the twentieth century. Their incidence dropped
to less than 2% during the latter half of the same century in
developed countries but it continues to constitute a significant
proportion of intracranial mass lesions in developing countries
(8-12%)7. The clinical features of intracranial tuberculomas
are related to the mass effect, local or general, produced by the
lesion (Table 2).

TABLE 2
Staging of Patient with TBM (Ref 35)
STAGING
Stage 1
Stage 2
Stage 3

CLINICAL MANIFESTATIONS
Fully conscious, no focal neurological deficits
Inattentive, confused, focal neurological signs
Coma, stupor, multiple cranial nerve palsies,
hemiplegia or paraplegia

Tuberculomas in the spinal cord may present with
signs and symptoms of myelopathy spinal cord compression,
or rarely radiculopathy8.
Tubercular Brain Abscess
TBA is a rare form of central nervous system
tuberculosis. It is characterized by an encapsulated collection
of pus, containing viable tubercular bacilli with or without
evidence of tubercular granuloma9. Not more than 25 cases
have been reported so far in literature. They are typically larger
than tuberculomas and evolve rapidly. The exact mechanism
of their formation is unknown. Occasionally tuberculomas may
contain super-infection by other bacteria10. The signs and
symptoms due to TBA may not be much different than those
from TBT except for its fast progression (Table3).

Table 3
Predictors of Poor Prognosis in CNS TB (Ref. 29-33)
Clinical condition
•
Decreased mental status
•
Focal neurological deficits
•
Cranial nerve palsies
•
Convulsions
•
Mechanical ventilation
Coexisting miliary or extrameningeal
tuberculosis/ coinfection with HIV
Age
•
Very young
•
Age greater than 60 years
CSF values
•
Culture positive for MTB
•
Raised protein
•
Reduced glucose
Delayed or interrupted treatment

Tuberculous Encephalopathy
TBE is another rare outcome of TB invading CNS.
It is usually more common in younger population and is
characterized by diffuse brain edema and demyelination which
usually is extensive11. Microscopically it is characterized by
microvascular necrosis with perivascular macrophage reaction
and demyelination along with focal glial nodules in the white
matter and occasional hemorrhagic lesions. Combination of
progressive tuberculosis along with severe alcoholic intoxication
ahs been characterized as acute toxic encephalopathy syndrome12.
This syndrome is characterized by impaired consciousness,
epileptic seizures, disseminated intravascular coagulation, signs
and symptoms of meningitis without spinal fluid changes. This
syndrome may be one of the leading causes of neurologic
devastation and death in CNS TB patients with high alcohol
intake.
Spinal tuberculosis (Pott’s disease), the most common
form of skeletal tuberculosis will be mentioned here briefly as
it frequently leads to neurologic deficits. It may result in serious
consequences like deformity and paraplegia due to bony
destruction. TB spine may also lead to epidural tuberculous
abscess or less commonly subdural tuberculous abscess. An
increased predominance of spinal TB in immunocompromised
individuals has been noted. Chemotherapy is the mainstay of
treatment, with surgical procedures reserved for cases which
are medically untreatable.
Diagnosis
Both TBT and TBA remain difficult to diagnose and
rapid-turn around testing with high predictive values is needed.
Clinical features supported by indirect evidence such as CSF
examination and imaging studies of the head and spine have
been used for early diagnosis. The differentials to be considered
Oct - Dec 2004 . 101

in tuberculous meningitis are other bacterial meningitides,
fungal infections, central nervous system toxoplasmosis and
central nervous system lymphoma. The differential diagnosis
of tuberculoma should include sarcoid granuloma, primary
brain tumors, pyogenic abscess, fungal infections, cystic
astrocytoma, lymphoma, cysticercosis and metastatic lesions.
The differential diagnosis in AIDS patients must include
opportunistic infections such as toxoplasmosis.
Laboratory Methods
Conventional bacteriological methods rarely detect
Mycobacterium tuberculosis in cerebrospinal fluid (CSF) and
are of limited use in the diagnosis of TBM. CSF protein between
100-200 mg/dl, CSF glucose less than 40 mg/dl, CSF leukocyte
count between 50-500/microl with predominant CSF
lymphocytes are considered characteristic findings in TBM
patients13. Tuberculous meningitis could be confirmed in half
of clinically suspected cases by this method.
Polymerase Chain Reaction (PCR) offers a rapid and
fairly accurate diagnosis of tuberculous meningitis14,15. Although
specificity and sensitivity as high as 100% have been reported,
until there is advancement in PCR technique, this test alone is
insufficient as a single diagnostic test for tuberculosis16,17.
Furthermore, in recent studies, immunological diagnostic
techniques were found to be superior to PCR. These methods,
owing to their rapid yield and easier method,also seem convenient
for use in laboratories in the developing world18. Gene probes,
gene amplification methods and in situ approaches offer
unparalleled capability to enhance the diagnosis of tuberculosis
in the near future19.
Radiological Evaluation
Modern imaging is a cornerstone in the early diagnosis
of central nervous system tuberculosis and may prevent
unnecessary morbidity and mortality.
Chest X-ray:
The chest x-ray in patients with central nervous system
tuberculosis may show features of miliary or pulmonary
tuberculosis. In about 47% of central nervous system tuberculosis
patients, the CXR may not reveal any abnormalities 20 .
Computerized Tomography (CT):
In patients with tuberculous meningitis, hydrocephalus
is the most common (80%) abnormality detected by CT. Less
commonly; parenchymal/basal cistern enhancement is noted.
Cerebral infarcts and surrounding edema can be detected in
approximately 13% of patients, while tuberculomas can be
detected in up to 5% of patients with tuberculous meningitis.
The CT can be normal in up to 12% of patients 20 .
102 . Infectious Diseases Journal of Pakistan

In patients with tuberculomas, the characteristic CT
finding is a nodular enhancing lesion with a central hypodense
region. Such a lesion arising due to tuberculous involvement
of the central nervous system is difficult to differentiate on CT
from other intracranial diseases i.e. abscesses, neoplasms,
multiple sclerosis, gliosis etc.21. Extensive surrounding edema
and mass effects are usually seen in the acute inflammatory
stage but are not as prominent in chronic tuberculomas20. The
appearance of TBA on CT is similar tuberculomas and to that
of other intracranial abscesses, showing lesions with central
hypodensity and peripheral enhancement.
Magnetic Resonance Imaging (MRI):
Contrast enhanced MRI is generally considered as the
modality of choice for detecting and assessing central nervous
system involvement by tuberculosis. The MRI may demonstrate
localized lesions and meningeal enhancement22,23. It is useful
for assessment of the location of lesions and their margins, as
well as ventriculitis, meningitis and spinal involvement
(sensitivity 86%, specificity 90%). Choroid plexus enhancement
with ventricular enlargement on MRI is highly suggestive of
TBM. In TBM, MRI shows diffuse, thick, meningeal
enhancement. Cerebral infarcts can be seen in nearly 30% of
cases24. While current radiological methods such as CT and
MRI are able to identify abnormalities highly suggestive and
in some cases diagnostic of TBM, their overall diagnostic yield
is less than optimal.
The MRI features of the individual tuberculoma depend
on whether the granuloma is non-caseating, caseating with a
solid center, or caseating with a liquid center. The non-caseating
granuloma usually is hypointense relative to brain on T1-W
images and hyperintense on T2-Weighted (T2-W) images and,
shows homogenous post-contrast enhancement. The caseating
granuloma with solid caseation appears relatively hypointense
or isointense on T1-W images and isointense to hypointense
on T2-W images. The granulomas with central liquefaction of
the caseous material appear centrally hypointense on T1-W
image and hyperintense on T2-W images with a peripheral
hypointense rim on T2-W images. Gadolinium enhanced T1W images show rim enhancement in caseating granulomas.
Role of Biopsy
Establishing a diagnosis of TBT can be very
challenging as the TBT lesions are similar to myriad of other
lesions on imaging studies. Accurate diagnosis of tuberculoma
is not possible until the brain lesion in question is subjected to
histopathological examination. Seven out of 13 patients, who
underwent biopsy at AKUH for suspicion of tuberculoma, had
other diagnoses (unpublished observations). Although surgical
intervention is considered mandatory in clinically diagnosed
tuberculoma patients with worsening clinical or radiological
features, definite guidelines regarding surgical biopsy for
diagnosis are lacking.

Treatment and Prognosis
Anti-tubercular therapy (ATT) is the mainstay of
management in central nervous system tuberculosis. Metaanalysis and RCT have suggested that corticosteroids are
beneficial in the survival of patients with CNS TB25,26. The
duration of ATT may need to be adjusted to radiological response
when treating tuberculomas27. Despite ATT, mortality is reported
to be high in tubercular abscesses9.
Surgery has a role both in the diagnosis and treatment
of tuberculoma. It is usually indicated in cases of clinical
deterioration that fail to respond to medical management and
when the diagnosis of tuberculoma is in doubt. Surgical
treatment options for TBA include simple puncture, continuous
drainage, fractional drainage, repeated aspiration through a burr
hole, stereotactic aspiration and total excision of the abscess.
Ventriculoperitoneal shunts may be required in patients with
TBM or TBT who develop obstructive hydrocephalus.
Ventriculoperitoneal shunt should be performed at the time the
need for shunting is determined and should not be delayed
waiting for the infection to resolve 28.
Despite prompt initiation of effective ATT, central
nervous system tuberculosis continues to have a poor prognosis.
Complications of tuberculous meningitis constitute the major
causes of morbidity and mortality of central nervous system
tuberculosis, especially in the pediatric population.
Patients with stage 1 disease at presentation usually
make a complete recovery or are left with only mild neurological
deficits, while around 30% of patients with advanced stage at
presentation succumb to severe residual neurological sequelae29.
Those who survive central nervous system tuberculosis are left
with serious dysfunctions such as cognitive disturbances,
seizures, hemiparesis, ataxia, visual impairment, optic atrophy
and other persistent cranial nerve palsies. Children and older
persons, because of their less competent immune systems are
more vulnerable to contracting central nervous system
tuberculosis. In a recent study, approximately 28% of paediatric
patients with central nervous system tuberculosis died and 40%
were left with permanent severe neurological sequelae30. Some
of the predictors of poor prognosis in patients with central
nervous system tuberculosis are shown in table 3. It is likely
that BCG protects against a fatal outcome in tuberculous
meningitis36.
Conclusion
Central nervous system tuberculosis is one of the more
severe forms of extra-pulmonary tuberculosis. There has been
a significant increase in the incidence of CNS TB worldwide
over the last couple of decades.

laboratory studies of the CSF and/or visualization of a lesion
on CT or MRI. Newer diagnostic techniques, such as PCR,
have not been assessed completely and are not possible in most
settings in the developing world. Neurosurgeons have been
actively involved in the treatment of central nervous system
tuberculosis due to its propensity to cause obstructive
hydrocephalus, intracranial mass lesions, and compressive
myelopathy. Surgery has a role both in the diagnosis and/or
treatment of tuberculoma and tubercular brain abscess although
definite guidelines have yet to be formulated. A high index
of suspicion is required in order to avoid delays in diagnosis,
which may influence treatment outcome. Death may occur as
a result of missed diagnosis and delayed treatment.
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